NovelStem International (NSTM) Selling, General & Administrative (2010 - 2026)
NovelStem International (NSTM) recorded Selling, General & Administrative of $34,935 in Q2 2026, down 45.4% from $63,964 a year earlier but up 605.3% from the prior quarter.
Powered by 
Analysis
NovelStem International (NSTM) Selling, General & Administrative (2010 - 2026) Analysis & Trends
On a TTM basis, NovelStem International's Selling, General & Administrative came in at $120,105 as of Jun 30, 2026, down 83.1% year-over-year; for FY2025, it was $238,755, down 72.9% from FY2024.
- Annual Selling, General & Administrative has a four-year compound annual growth rate of -16.7% (FY2021 to FY2025).
- Across earlier years, Selling, General & Administrative came in at $880,947 in FY2024, $744,434 in FY2022 (+50.2%) and $495,535 in FY2021.
- Quarterly Selling, General & Administrative has ranged from -$12,940 in Q4 2024 to $566,551 in Q3 2024 over the past five years.
- Per Business Quant, the preceding three quarters came in at $4,953 (Q1 2026), $40,748 (Q4 2025) and $39,469 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | NovelStem International | 493,324.54 | 346,279.54 | - | 34,935.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34,935.00 |
| Mar 31, 2026 | 4,953.00 |
| Dec 31, 2025 | 40,748.00 |
| Sep 30, 2025 | 39,469.00 |
| Jun 30, 2025 | 63,964.00 |
| Mar 31, 2025 | 94,574.00 |
| Dec 31, 2024 | -12,940.00 |
| Sep 30, 2024 | 566,551.00 |
| Jun 30, 2024 | 144,030.00 |
| Mar 31, 2024 | 183,306.00 |
| Sep 30, 2023 | 84,208.00 |
| Jun 30, 2023 | 386,361.00 |
| Mar 31, 2023 | 164,792.00 |
| Dec 31, 2022 | 169,693.00 |
| Sep 30, 2022 | 206,210.00 |
| Jun 30, 2022 | 229,575.00 |
| Mar 31, 2022 | 138,956.00 |
| Dec 31, 2021 | 359,488.00 |
| Sep 30, 2021 | 60,133.00 |
| Sep 30, 2013 | 882,951.00 |
API Access
NovelStem International Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NSTM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "NSTM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=NSTM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();